La catena delle opzioni mostra i dati chiave delle opzioni azionarie di GeneDx Holdings a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per GeneDx Holdings..

GeneDx Holdings (NASDAQ:WGS) Azioni, Catena delle Opzioni

GeneDx Holdings

GeneDx Hldgs

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

LFCR

SPSC

Analisi delle performance di GeneDx, Lifecore Biomedical, UDR e i loro ultimi sviluppi nel mercato per il trading di oggi.

Resources Connection, SPS Commerce e altre 3 azioni da tenere d&#39;occhio

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Holdings Corp

Press Releases

Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS

Legal

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Management

Seer Appoints Isaac Ro to its Board of Directors

GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating GeneDx Holdings Corp. on Behalf of Stockholders and Encourages Investors to Contact the Firm

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

SEER

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna Group

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Comments

GeneDx Holdings

GeneDx Holdings (WGS) Opzioni

GeneDx Holdings (NASDAQ:WGS) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO